Back
Sonnet BioTherapeutics Holdings, Inc. 10K Form
Sell
8
SONN
Sonnet BioTherapeutics Holdings, Inc.
Last Price:
$1.26
Seasonality Move:
-4.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SONN News And Ratings
See the #1 stock for the next 7 days that we like better than SONN
SONN Financial Statistics
Sales & Book Value
| Annual Sales: | $1M |
|---|---|
| Cash Flow: | $-5.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.52 |
| Price / Book: | 0.73 |
Profitability
| EPS (TTM): | -4.20820 |
|---|---|
| Net Income (TTM): | $-16M |
| Gross Margin: | $910.7K |
| Return on Equity: | -669.7% |
| Return on Assets: | -260.53% |
Sonnet BioTherapeutics Holdings, Inc. Earnings Forecast
Key Sonnet BioTherapeutics Holdings, Inc. Financial Ratios
-
The Gross Profit Margin over the past 18 years for SONN is 91.07%.
-
The Selling, General & Administrative Expenses for SONN have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 833.37% of Revenue.
-
The Net Earning history of SONN is -1,601.15% of Total Revenues.
-
Per Share Earnings over the last 18 years have been positive in 14 years.
Sonnet BioTherapeutics Holdings, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SONN |
| Website: | sonnetbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.5 |
| Quick Ratio: | 3.26 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SONN Technical Analysis vs Fundamental Analysis
Sell
8
Sonnet BioTherapeutics Holdings, Inc. (SONN)
is a Sell
Is Sonnet BioTherapeutics Holdings, Inc. a Buy or a Sell?
-
Sonnet BioTherapeutics Holdings, Inc. stock is rated a SellThe current Sonnet BioTherapeutics Holdings, Inc. [SONN] share price is $1.26. The Score for SONN is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.